- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03710538
The Effect of a Pre-meal Snack and/or Exercise on Post-prandial Glycemic Excursions in Adults With Cystic Fibrosis (SNACK_CF)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The investigators are proposing a randomized pilot study to explore the impact of a soy beverage of carbohydrates and protein early in the morning, to stimulate and initiate secretion of Insulin to reduce PPG excursions of the following a lunch in adult patients with CF. Investigators will also study the impact of a post meal exercise on the PPG excursion. Fourteen participants will be included and will each perform a 4-hour intervention in cross over design according to those 4 following experimental conditions:
- Consumption of 200ml of water (flavored) + breakfast of 90g of carbohydrates (CHO) for men and 80g for women; Sedentary activities throughout the study [condition control]
- Consumption of 200ml of soy beverage + 90g of carbohydrate (CHO) breakfast for men and 80g for women; Sedentary activities throughout the study [snack effect on PPG excursion]
- Consumption of 200ml of water (flavored) + breakfast of 90g of carbohydrates (CHO) for men and 80g for women + physical activity practice (3min walk at 60% VO2max every 30 minutes, x5); [exercise effect on the PPG excursion]
- Consumption of 200ml of soy beverage + breakfast of 90g of carbohydrate (CHO) breakfast for men and 80g for women + physical activity practice (3min walk at 60% VO2max every 30 minutes, x5). [Combined snack and exercise effect on the PPG excursion] Main result: plasma glucose area under the curve. The underlying mechanisms, insulin, incretin hormones (GLP-1 and GIP), acceptability and side effects (mealtime hyperglycaemia) should also be measured. At the end of this pilot project, the investigators will have established a pre-meal snack and/ or postprandial exercise have a positive impact on PPG.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Quebec
-
Montreal, Quebec, Canada, H2W 1R7
- Institut de recherches cliniques de Montréal (IRCM)
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Diagnosis of cystic fibrosis,
- Be over 18 years old.
Exclusion Criteria:
- Pharmacological treatment for cystic fibrosis related diabetes.
- Signs of secondary infection: the test will be practiced at least 1 month after the end of infection treatment
- People with severe gastrointestinal illness (Crohn's disease, celiac disease and a recent history (<1 year) of bowel obstruction).
- Allergy to one of the ingredients of the menu (example: celiac disease)
- According to the judgment of the investigator, medications or conditions that could interfere with glucose metabolism (eg: oral steroids)
- Pregnancy in progress
- Corrector or potentiator prescribed whose dose is not stable the last 2 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: [Placebo + Sedentary]
1) Consumption of 200ml of water (flavored) + breakfast of 90g of carbohydrates (CHO) for men and 80g for women; Sedentary activities throughout the study
|
|
|
Experimental: [Snack effect + Sedentary]
2) Consumption of 200ml of soy beverage + 90g of carbohydrate (CHO) breakfast for men and 80g for women; Sedentary activities throughout the study
|
Consumption of a 200ml of soy beverage (100Kcal, 11g CHO, 6g proteins, 4g fat)
|
|
Experimental: [Placebo + Exercise]
3) Consumption of 200ml of water (flavored) + breakfast of 90g of carbohydrates (CHO) for men and 80g for women + physical activity practice (3min walk at 60% VO2max every 30 minutes, x5);
|
3min walk at 60% VO2max every 30 minutes,(x5)
|
|
Experimental: [Snack + Exercise]
4) Consumption of 200ml of soy beverage + breakfast of 90g of carbohydrate (CHO) breakfast for men and 80g for women + physical activity practice (3min walk at 60% VO2max every 30 minutes, x5).
|
Consumption of a 200ml of soy beverage (100Kcal, 11g CHO, 6g proteins, 4g fat)
3min walk at 60% VO2max every 30 minutes,(x5)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Total area under the curve for plasma glucose
Time Frame: Overall study period (4 hours)
|
Overall study period (4 hours)
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Area under the curve for plasma glucose
Time Frame: From start of study to breakfast time (1 hour)
|
From start of study to breakfast time (1 hour)
|
|
Area under the curve for plasma glucose
Time Frame: From time of breakfast to the end of the study (3 hours)
|
From time of breakfast to the end of the study (3 hours)
|
|
Total area under the curve for insulin
Time Frame: Overall study period (4 hours)
|
Overall study period (4 hours)
|
|
Area under the curve for insulin
Time Frame: From start of study to breakfast time (1 hour)
|
From start of study to breakfast time (1 hour)
|
|
Area under the curve for insulin
Time Frame: From breakfast time to the end of the study (3 hours)
|
From breakfast time to the end of the study (3 hours)
|
|
Mean plasma glucose
Time Frame: Overall study period (4 hours)
|
Overall study period (4 hours)
|
|
Mean insulin
Time Frame: Overall study period (4 hours)
|
Overall study period (4 hours)
|
|
Percentage of time with plasma glucose concentration above 8.0 mmol/L
Time Frame: Overall study period (4 hours)
|
Overall study period (4 hours)
|
|
Percentage of time with plasma glucose concentration above 10.0 mmol/L
Time Frame: Overall study period (4 hours)
|
Overall study period (4 hours)
|
|
Percentage of time with plasma glucose concentration above 11.0 mmol/L
Time Frame: Overall study period (4 hours)
|
Overall study period (4 hours)
|
|
Percentage of time with plasma glucose concentration below 4.0 mmol/L
Time Frame: Overall study period (4 hours)
|
Overall study period (4 hours)
|
|
Post-breakfast peak plasma glucose
Time Frame: 1 hour after breakfast
|
1 hour after breakfast
|
Collaborators and Investigators
Investigators
- Principal Investigator: Rémi Rabasa-Lhoret, MD, PhD, IRCM
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SNACK_CF
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cystic Fibrosis
-
Hospital de Clinicas de Porto AlegreUnknownCystic Fibrosis | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in Children | Cystic Fibrosis With ExacerbationBrazil
-
Dartmouth-Hitchcock Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingCystic Fibrosis (CF) | Cystic Fibrosis Gastrointestinal DiseaseUnited States
-
Haisco Pharmaceutical Group Co., Ltd.RecruitingNon-cystic Fibrosis BronchiectasisChina
-
AstraZenecaRecruitingNon-cystic Fibrosis BronchiectasisChina
-
Reistone Biopharma Company LimitedRecruiting
-
Alexander HorsleyRecruitingCystic Fibrosis (CF) | Cystic Fibrosis Pulmonary ExacerbationUnited Kingdom
-
University of Colorado, DenverCystic Fibrosis FoundationTerminatedCystic Fibrosis-related Diabetes | Cystic Fibrosis Pulmonary Exacerbation | Cystic Fibrosis in ChildrenUnited States
-
Royal College of Surgeons, IrelandThe Hospital for Sick Children; Imperial College London; Erasmus Medical Center; University College Dublin and other collaboratorsActive, not recruitingCystic Fibrosis | Adherence, Medication | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis in Children | Cystic Fibrosis Liver DiseaseUnited Kingdom, Ireland
-
Herlev and Gentofte HospitalCopenhagen University Hospital, DenmarkActive, not recruitingMyocardial Infarction | Heart Diseases | Heart Failure | Stroke | Cystic Fibrosis | Heart Failure, Diastolic | Heart Failure, Systolic | Left Ventricular Dysfunction | Cystic Fibrosis-related Diabetes | Cystic Fibrosis Gastrointestinal Disease | Cystic Fibrosis of Pancreas | Cystic Fibrosis, Pulmonary | Cystic...Denmark
-
Alexander HorsleyRecruitingCystic Fibrosis (CF) | Cystic Fibrosis Pulmonary ExacerbationUnited Kingdom
Clinical Trials on Snack beverage
-
University of Arkansas, FayettevilleCompleted
-
Penn State UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity | Feeding BehaviorsUnited States
-
Purdue UniversityCompleted
-
Texas Tech University Health Sciences CenterNot yet recruiting
-
Harokopio UniversityNational and Kapodistrian University of AthensCompletedOverweight and ObesityGreece
-
Ocean Spray Cranberries, Inc.Completed
-
King's College LondonRecruitingImmune ResponseUnited Kingdom
-
King's College LondonCompletedDepression | AnxietyUnited Kingdom
-
Rutgers, The State University of New JerseyRecruitingWeight Loss | Bone Density | Obesity and OverweightUnited States